We observed increased miR-342 expression in AML samples, especially in patients without a FLT3 mutation, compared to healthy BM-derived mononuclear cells that did not reach statistical significance (P = 0.06; Fig. 6c). The gene discussed is FLT3; the disease is acute myeloid leukemia.